Predicting the Quality of Response to Specific Treatments in Patients With cGVHD, PQRST Study

RecruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

June 29, 2020

Primary Completion Date

August 2, 2026

Study Completion Date

August 2, 2026

Conditions
Chronic Graft Versus Host Disease
Interventions
PROCEDURE

Biospecimen Collection

Undergo collection of blood sample

OTHER

Medical Chart Review

Review of medical chart

OTHER

Quality-of-Life Assessment

Ancillary studies

OTHER

Questionnaire Administration

Complete questionnaire

Trial Locations (10)

14263

COMPLETED

Roswell Park Cancer Institute, Buffalo

15232

COMPLETED

UPMC Hillman Cancer Center, Pittsburgh

32610

COMPLETED

University of Florida, Gainesville

33612

RECRUITING

Moffitt Cancer Center, Tampa

37232

COMPLETED

Vanderbilt University/Ingram Cancer Center, Nashville

44195

RECRUITING

Cleveland Clinic Foundation, Cleveland

55455

COMPLETED

University of Minnesota/Masonic Cancer Center, Minneapolis

98109

RECRUITING

Fred Hutch/University of Washington Cancer Consortium, Seattle

02115

RECRUITING

Dana-Farber Harvard Cancer Center, Boston

V5Z 4E6

COMPLETED

Vancouver General Hospital/BC Cancer, Vancouver

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Fred Hutchinson Cancer Center

OTHER